Systemic application of the TRPV4 antagonist GSK2193874 induces tail vasodilation in a mouse model of thermoregulation

التفاصيل البيبلوغرافية
العنوان: Systemic application of the TRPV4 antagonist GSK2193874 induces tail vasodilation in a mouse model of thermoregulation
المؤلفون: Caroline A. Staunton, Fiona O'Brien, Richard Barrett-Jolley
بيانات النشر: Cold Spring Harbor Laboratory, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, Chemistry, Antagonist, Vasodilation, Blood flow, Thermoregulation, Blood–brain barrier, medicine.anatomical_structure, Blood pressure, Endocrinology, Hypothalamus, Internal medicine, Heart rate, medicine
الوصف: In humans the skin is a primary thermoregulatory organ, with vasodilation leading to rapid body cooling, whereas in Rodentia the tail performs an analogous function. Many thermodetection mechanisms are likely to be involved including transient receptor potential vanilloid-type 4 (TRPV4), a widely distributed ion channel with both mechanical and thermosensitive properties. Previous studies have shown that TRPV4 can act as a vasodilator by local action in blood vessels, and in this study, we investigated whether TRPV4 activity effects mus muscularis tail vascular tone and thermoregulation. We measured tail blood flow by pressure plethysmography in lightly sedated mus muscularis (CD1 strain) at a range of ambient temperatures, with and without intraperitoneal administration of the blood brain barrier crossing TRPV4 antagonist GSK2193874. We also measured heart rate and blood pressure with and without GSK2193874. As expected for a thermoregulatory organ, we found that tail blood flow increased with temperature. However, unexpectedly we found that the TRPV4 antagonist GSK2193874 increased tail blood flow at all temperatures, and we observed changes in heart rate variability. Since TRPV4 activation stimulates the relaxation of peripheral resistance arteries (vasodilation) that would increase tail blood flow, these data suggest that increases in tail blood flow resulting from the TRPV4 antagonist may arise from a site other than the blood vessels themselves, perhaps in central cardiovascular control centres such as the hypothalamus.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b6b7742ed8aef984b1e7ea0718b6a6df
https://doi.org/10.1101/2021.03.12.435126
حقوق: OPEN
رقم الأكسشن: edsair.doi...........b6b7742ed8aef984b1e7ea0718b6a6df
قاعدة البيانات: OpenAIRE